HOME › DRUGS › TICAGRELOR
ACTIVE SUBSTANCE / INN

TICAGRELOR

Brand name(s): BRILINTA, Possia, TICAGRELOR, Brilique
FDA LISTED
EMA LISTED
DISCONTINUED
PRESCRIPTION
WITHDRAWN
ANDA208597
ANDA208599
ACTIVE SUBSTANCE
Ticagrelor
REGULATORS
FDA · EMA
SPONSORS / MAH
AstraZeneca AB, AMNEAL, ASTRAZENECA
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TICAGRELORANDA208597MYLANPrescription
TICAGRELORANDA208599PRINSTON INCNone (Tentative Approval)
BRILINTANDA022433ASTRAZENECAPrescription
TICAGRELORANDA208531AMNEALDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
BriliqueAstraZeneca ABAuthorised03/12/2010Peripheral Vascular Diseases;Acute Coronary Syndrome
PossiaAstraZeneca ABWithdrawn03/12/2010Peripheral Vascular Diseases;Acute Coronary Syndrome

FULL INTELLIGENCE ON TICAGRELOR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →